Table 2 Characteristics of the study population at first diaphragm assessment and during intensive care unit stay
Diaphragm dysfunction on admission n = 23 | No diaphragm dysfunction on admission n = 20 | p | |||
|---|---|---|---|---|---|
Persistent dysfunction n = 14 | Improving dysfunction n = 9 | ICU-acquired dysfunction n = 11 | No dysfunction n = 9 | ||
At first diaphragm assessment | |||||
SOFA | 9 (8–10) | 9 (5–11) | 8 (7–8) | 6 (4–10) | 0.573 |
Sepsis [n (%)] | 11 (79) | 7 (78) | 6 (55) | 3 (33) | 0.121 |
PaO2/FiO2 (mmHg) | 211 (141–302) | 208 (143–281) | 202 (120–295) | 314 (120–460) | 0.593 |
PaCO2 (mmHg) | 38 (33–45) | 36 (31–37) | 33 (31–38) | 35 (31–39) | 0.635 |
pH | 7.41 (7.31–7.46) | 7.41 (7.33–7.47) | 7.39 (7.33–7.49) | 7.45 (7.31–7.49) | 0.854 |
Blood lactate (mmol/L) | 2.5 (1.3–3.2) | 1.5 (1.2–2.9) | 2.3 (1.7–3.4) | 1.9 (1.2–3.00) | 0.626 |
During ICU stay | |||||
Sedation (% of ICU stay) | 54 (30–75) | 67 (25–71) | 50 (33–73) | 33 (13–43) | 0.302 |
Amines (% of ICU stay) | 100 (0–100) | 100 (0–100) | 6 (0–100) | 0 (0–71) | 0.189 |
Controlled MV (% of ICU stay) | 64 (43–80) | 71 (25–83) | 50 (33–75) | 33 (25–43) | 0.610 |